Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study (Q77619532)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 1998

Language	Label	Description	Also known as
English	Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study	scientific article published on 01 November 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

based on heuristic

inferred from title

primary biliary cholangitis

0 references

1 reference

based on heuristic

inferred from title

author name string

F H Wolfhagen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H J van Hoogstraten

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H R van Buuren

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G P van Berge-Henegouwen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F J ten Kate

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

W C Hop

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E W van der Hoek

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M J Kerbert

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H H van Lijf

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J W den Ouden

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A M Smit

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R A de Vries

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R A van Zanten

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S W Schalm

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

736-742

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary biliary cirrhosis--a first step in prolonging survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosupressive therapy for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980254-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(98)80254-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833911%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77619532&oldid=1584402590"